Back
Rhythm Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$107.09
Seasonality Move:
-16.52%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and RYTM is experiencing slight selling pressure.
Rhythm Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.75 | Sell |
| 20-day SMA: | 109.57 | Sell |
| 50-day SMA: | 106.89 | Buy |
| 200-day SMA: | 85.31 | Buy |
| 8-day EMA: | 100.86 | Buy |
| 20-day EMA: | 69.88 | Buy |
| 50-day EMA: | 36.53 | Buy |
| 200-day EMA: | 10.56 | Buy |
Rhythm Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 30.07 | Buy |
| Relative Strength Index (14 RSI): | 47.08 | Sell |
| Chaikin Money Flow: | -172773 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.77 - 113.07) | Sell |
| Bollinger Bands (100): | (97.88 - 109.44) | Buy |
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rhythm Pharmaceuticals, Inc. Stock
Is Rhythm Pharmaceuticals, Inc. Stock a Buy?
-
Rhythm Pharmaceuticals, Inc. share price is 107.04 while RYTM 8-day simple moving average is 110.75, which is a Sell signal.
-
The stock price of RYTM is 107.04 while Rhythm Pharmaceuticals, Inc. 20-day SMA is 109.57, which makes it a Sell.
-
Rhythm Pharmaceuticals, Inc. 50-day simple moving average is 106.89 while RYTM share price is 107.04, making it a Buy technically.
-
RYTM stock price is 107.04 and Rhythm Pharmaceuticals, Inc. 200-day simple moving average is 85.31, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Sell
36
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Sell
Is Rhythm Pharmaceuticals, Inc. a Buy or a Sell?
-
Rhythm Pharmaceuticals, Inc. stock is rated a SellThe current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $107.04. The Score for RYTM is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Rhythm Pharmaceuticals, Inc. Stock Info
Market Cap:
7.1B
Price in USD:
107.04
Share Volume:
507.3K
Rhythm Pharmaceuticals, Inc. 52-Week Range
52-Week High:
122.20
52-Week Low:
45.91
Sell
36
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Sell
Rhythm Pharmaceuticals, Inc. Share Price Forecast
-
What is the Rhythm Pharmaceuticals, Inc. stock price today?The Rhythm Pharmaceuticals, Inc. stock price is 107.04 USD today.
-
Will RYTM stock go up or go down?Rhythm Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Rhythm Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals, Inc. is overvalued.
Is Rhythm Pharmaceuticals, Inc. Stock a Buy?
-
Rhythm Pharmaceuticals, Inc. share price is 107.04 while RYTM 8-day exponential moving average is 100.86, which is a Buy signal.
-
The stock price of RYTM is 107.04 while Rhythm Pharmaceuticals, Inc. 20-day EMA is 69.88, which makes it a Buy.
-
Rhythm Pharmaceuticals, Inc. 50-day exponential moving average is 36.53 while RYTM share price is 107.04, making it a Buy technically.
-
RYTM stock price is 107.04 and Rhythm Pharmaceuticals, Inc. 200-day simple moving average is 10.56, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals, Inc.
Is Rhythm Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $3.26 per share.
Technical Analysis of Rhythm Pharmaceuticals, Inc.
Should I short Rhythm Pharmaceuticals, Inc. stock?
-
RYTM Moving Average Covergence Divergence (MACD) indicator is 30.07, suggesting Rhythm Pharmaceuticals, Inc. is a Buy
-
Rhythm Pharmaceuticals, Inc. Relative Strength Index (RSI) is 47.08, which suggest Rhythm Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for Rhythm Pharmaceuticals, Inc. is (104.77 - 113.07), which suggest Rhythm Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Rhythm Pharmaceuticals, Inc. is (97.88 - 109.44), which suggest Rhythm Pharmaceuticals, Inc. is a Buy
* Rhythm Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.